AI assistant
InspireMD, Inc. — Director's Dealing 2023
May 19, 2023
34187_dirs_2023-05-19_bd83edc6-a83b-4e2c-95ee-ce836da747ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-05-17
Reporting Person: BERMAN MICHAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-17 | Common Stock | A | 149260 | — | Acquired | 192087 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | Options to purchase common stock (right to buy) | $1.76 | A | 49750 | Acquired | 2033-05-17 | Common Stock (49750) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 122497 | Indirect |
Footnotes
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three
equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to
the Reporting Person's continued service.
F2: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the
Reporting Person with respect to these securities, and they are being included in this Form 4 for informational
purposes only.
F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024,
May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.